Related Experiment Video
Updated: Jun 24, 2026

Osmotic Avoidance in Caenorhabditis elegans: Synaptic Function of Two Genes, Orthologues of Human NRXN1 and NLGN1, as Candidates for Autism
Published on: December 12, 2009
Concomitant loss of dynorphin, NARP, and orexin in narcolepsy
A Crocker1, R A España, M Papadopoulou
1Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Background:
Narcolepsy with cataplexy is associated with a loss of orexin/hypocretin. It is speculated that an autoimmune process kills the orexin-producing neurons, but these cells may survive yet fail to produce orexin.
Objective:
To examine whether other markers of the orexin neurons are lost in narcolepsy with cataplexy.
Methods:
We used immunohistochemistry and in situ hybridization to examine the expression of orexin, neuronal activity-regulated pentraxin (NARP), and prodynorphin in hypothalami from five control and two narcoleptic individuals.
Results:
In the control hypothalami, at least 80% of the orexin-producing neurons also contained prodynorphin mRNA and NARP. In the patients with narcolepsy, the number of cells producing these markers was reduced to about 5 to 10% of normal.
Conclusions:
Narcolepsy with cataplexy is likely caused by a loss of the orexin-producing neurons. In addition, loss of dynorphin and neuronal activity-regulated pentraxin may contribute to the symptoms of narcolepsy.
Insights
Narcolepsy with cataplexy involves the loss of orexin-producing neurons. This study found that markers like prodynorphin and neuronal activity-regulated pentraxin (NARP) are also significantly reduced in narcolepsy patients.
Area of Science:
- Neuroscience
- Sleep Medicine
Background:
- Narcolepsy with cataplexy is linked to orexin/hypocretin deficiency.
- The exact cause is debated, with theories including autoimmune destruction or functional failure of orexin neurons.
Purpose of the Study:
- To investigate the loss of other orexin neuron markers in narcolepsy with cataplexy.
- To determine if neuronal activity-regulated pentraxin (NARP) and prodynorphin are affected.
Main Methods:
- Immunohistochemistry and in situ hybridization were employed.
- Hypothalami from control and narcolepsy patients were analyzed for orexin, NARP, and prodynorphin expression.
Main Results:
- In controls, over 80% of orexin neurons expressed prodynorphin mRNA and NARP.
- Narcolepsy patients showed a drastic reduction, with only 5-10% of normal levels for these markers.
Conclusions:
- The findings strongly suggest a loss of orexin-producing neurons in narcolepsy with cataplexy.
- Reduced dynorphin and NARP may also play a role in narcolepsy symptoms.
Related Concept Videos
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Management of Insomnia
Narcolepsy
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...

